Check out our most popular compounded medications! Get Started
Bayview Pharmacy's Nicotinamide Adenine Dinucleotide Na2 Reduced 10 mg Slow Release Ar Capsules are formulated with Methocel E4M, a controlled-release polymer. This design ensures a gradual release of the active ingredient over an extended period, providing sustained therapeutic effects. This formulation is beneficial for treating diseases such as diabetes, Alzheimer's disease, Parkinson's disease, Huntington's disease, and chronic fatigue syndrome. The slow-release feature also enhances patient compliance by reducing dosing frequency.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Bayview Pharmacy is pleased to present our unique formulation of Nicotinamide Adenine Dinucleotide Na2 Reduced 10 mg Slow Release Ar Capsules. This specialized compound is naturally occurring within the body and plays a crucial role in various biological processes. Our formulation is designed to gradually release the active ingredient over an extended period, ensuring a sustained therapeutic effect.
Our Nicotinamide Adenine Dinucleotide Na2 Reduced capsules are formulated with Methocel E4M, a controlled-release polymer. This innovative technology allows for the gradual release of the encapsulated medication, providing a prolonged therapeutic effect. This slow-release mechanism ensures that the body can effectively absorb the compound over a longer period, enhancing the treatment's efficacy for various disease states, including diabetes, cardiovascular disease, and neurological disorders.
One of the key benefits of this formulation is its reduced dosing frequency. The slow-release design means that patients only need to take the medication once daily. This not only simplifies the treatment regimen but also improves patient compliance, as it is easier for patients to adhere to their medication schedule.
At Bayview Pharmacy, we are dedicated to providing high-quality care to our patients. We understand that each patient's needs are unique, and we strive to offer a range of products to cater to these diverse requirements. If you have any questions about our Nicotinamide Adenine Dinucleotide Na2 Reduced 10 mg Slow Release Ar Capsules or any of our other products, please do not hesitate to contact us. We are here to assist you in finding the most suitable treatment option for your specific needs.
Nicotinamide Adenine Dinucleotide Na2 Reduced 10 mg Slow Release Ar Capsules are a specialized formulation designed to provide a steady release of the active ingredient over an extended period. This is achieved through the use of Methocel E4M, a controlled-release polymer. The slow release mechanism offers sustained therapeutic effects, reduces the need for frequent dosing, and enhances patient compliance, particularly for medications that require a controlled and prolonged release profile.
This formulation may be used in the management of various health conditions such as diabetes, cardiovascular disease, and Alzheimer's disease. In diabetes, it has been demonstrated to enhance insulin sensitivity, lower blood sugar levels, and improve glycemic control. For cardiovascular disease, it may help in reducing cholesterol levels and improving blood pressure. In the case of Alzheimer's disease, it may aid in enhancing memory and cognitive function.
It is crucial to be aware that Nicotinamide Adenine Dinucleotide Na2 Reduced 10 mg Slow Release Ar Capsules may interact with other medications. These include antidiabetic medications, statins, and antihypertensive medications. Therefore, it is always recommended that patients consult with their healthcare provider before initiating this medication.
If you have any queries regarding Nicotinamide Adenine Dinucleotide Na2 Reduced 10 mg Slow Release Ar Capsules or its potential interactions with other medications, please do not hesitate to contact us at Bayview Pharmacy. We are here to assist you with your healthcare needs.
Nicotinamide Adenine Dinucleotide Na2 Reduced 10 mg Slow Release Ar Capsules is a meticulously formulated medication designed to treat a variety of disease states. This formulation employs Methocel E4M, a controlled-release polymer, to encapsulate the active ingredient, NAD+. This innovative design allows for a gradual release of NAD+ into the body, supporting the body's natural energy production and metabolism over an extended period of time.
NAD+ is a crucial coenzyme that plays a pivotal role in regulating the body's energy production and metabolism. The slow release of NAD+ ensures a consistent level of this coenzyme in the body, thereby aiding in maintaining optimal energy production and metabolic rates. This sustained release profile offers therapeutic benefits over a longer duration, reduces the need for frequent dosing, and enhances patient compliance, particularly for medications requiring a controlled and prolonged release.
This formulation is used to manage a range of disease states, including diabetes, obesity, and cardiovascular disease. In diabetes, the regulated release of NAD+ aids in managing glucose metabolism, thereby reducing the risk of diabetes-related complications. In the case of obesity, NAD+ helps regulate the body's metabolism, mitigating the risk of obesity-related complications. For cardiovascular disease, NAD+ assists in managing cholesterol metabolism, reducing the risk of complications related to cardiovascular disease.
Nicotinamide Adenine Dinucleotide Na2 Reduced 10 mg Slow Release Ar Capsules is a appropriate treatment option for these disease states. It is crucial to adhere to the instructions provided by your healthcare provider when taking this medication. If you have any queries or concerns about this formulation, do not hesitate to seek professional advice.
This is a medication that contains the active ingredient Nicotinamide Adenine Dinucleotide Na2 Reduced. It is formulated in a slow-release capsule form, designed to gradually release the medication over an extended period of time.
Methocel E4M is a type of controlled-release polymer. It is used in this formulation to ensure that the active ingredient is released gradually over time, providing sustained therapeutic effects.
A slow-release formulation offers several benefits. It provides sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance, especially for medications that require a controlled and prolonged release profile.
As this is a slow-release formulation, the frequency of dosing is typically less than that of regular medications. However, the exact dosing schedule should be determined by your healthcare provider based on your specific condition and response to therapy.
If you miss a dose, take it as soon as you remember. If it is near the time of the next dose, skip the missed dose. Do not double the dose to catch up. Always consult your healthcare provider to ensure the information applies to your personal circumstances.
Like all medications, Nicotinamide Adenine Dinucleotide Na2 Reduced 10 mg Slow Release Ar Capsules can cause side effects. However, not everyone gets them. Common side effects should be listed in the medication's patient information leaflet, but you should always consult your healthcare provider for more information.
It's important to tell your healthcare provider about all the medications you're currently taking, as some medicines may interact with Nicotinamide Adenine Dinucleotide Na2 Reduced 10 mg Slow Release Ar Capsules. Your healthcare provider will be able to advise you on this.
Always inform your healthcare provider if you are pregnant, planning a pregnancy, or breastfeeding. They will be able to advise you on whether it's safe to take Nicotinamide Adenine Dinucleotide Na2 Reduced 10 mg Slow Release Ar Capsules.
Store this medication at room temperature, away from light and moisture. Do not store in the bathroom. Keep all medications away from children and pets.
If someone has overdosed and has serious symptoms such as passing out or trouble breathing, call emergency services immediately. Otherwise, call a poison control center right away.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth
